Insider Buy/Sell Details for the Biotechnology Industry — Last 3 Months
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (3396)
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
258
Price
$548.73
Total Value
$141.57K
Shares Held After
52,556
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
658
Price
$548.00
Total Value
$360.58K
Shares Held After
52,814
% of Holdings
1.2%
Neurogene Inc. (NGNE)
Cvijic Christine Mikail — Director
Shares
1,530
Price
$35.23
Total Value
$53.90K
Shares Held After
88,840
% of Holdings
1.7%
Neurogene Inc. (NGNE)
Cvijic Christine Mikail — Director
Shares
2,531
Price
$34.58
Total Value
$87.52K
Shares Held After
90,370
% of Holdings
2.7%
Nurix Therapeutics, Inc. (NRIX)
Ring Christine — Chief Legal Officer
Shares
11,008
Price
$23.56
Total Value
$259.37K
Shares Held After
13,579
% of Holdings
44.8%
Sol-Gel Technologies Ltd. (SLGL)
Opaleye Management Inc. — 10% Owner
Shares
1,400
Price
$71.97
Total Value
$100.76K
Shares Held After
491,712
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
40
Price
$558.37
Total Value
$22.33K
Shares Held After
40,513
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
320
Price
$557.63
Total Value
$178.44K
Shares Held After
40,553
% of Holdings
0.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,343
Price
$556.56
Total Value
$747.46K
Shares Held After
40,873
% of Holdings
3.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,942
Price
$555.67
Total Value
$1.63M
Shares Held After
42,216
% of Holdings
6.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,006
Price
$554.75
Total Value
$1.11M
Shares Held After
45,158
% of Holdings
4.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
776
Price
$553.64
Total Value
$429.62K
Shares Held After
47,164
% of Holdings
1.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
993
Price
$552.72
Total Value
$548.86K
Shares Held After
47,940
% of Holdings
2.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
640
Price
$551.59
Total Value
$353.02K
Shares Held After
48,933
% of Holdings
1.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
118
Price
$549.77
Total Value
$64.87K
Shares Held After
49,573
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
130
Price
$548.75
Total Value
$71.34K
Shares Held After
49,691
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
192
Price
$548.01
Total Value
$105.22K
Shares Held After
49,821
% of Holdings
0.4%
ImmunityBio, Inc. (IBRX)
Selecky Christobel — Director
Shares
159,478
Price
$9.02
Total Value
$1.44M
Shares Held After
0
% of Holdings
100.0%
PALISADE BIO, INC. (PALI)
Baltera Robert Jr. — Director
Shares
20,000
Price
$1.98
Total Value
$39.60K
Shares Held After
356,904
% of Holdings
5.6%
Adaptive Biotechnologies Corp (ADPT)
LO FRANCIS — Chief People Officer
Shares
42,261
Price
$22.50
Total Value
$950.87K
Shares Held After
237,688
% of Holdings
15.1%
Adaptive Biotechnologies Corp (ADPT)
LO FRANCIS — Chief People Officer
Shares
8,743
Price
$22.18
Total Value
$193.92K
Shares Held After
279,949
% of Holdings
3.0%
Adaptive Biotechnologies Corp (ADPT)
BOBULSKY SUSAN — Chief Commercial Officer, MRD
Shares
487
Price
$22.00
Total Value
$10.71K
Shares Held After
406,288
% of Holdings
0.1%
IONIS PHARMACEUTICALS INC (IONS)
KLEIN JOSEPH III — Director
Shares
11,419
Price
$79.04
Total Value
$902.55K
Shares Held After
11,014
% of Holdings
50.9%
IONIS PHARMACEUTICALS INC (IONS)
KLEIN JOSEPH III — Director
Shares
99
Price
$79.45
Total Value
$7.87K
Shares Held After
22,433
% of Holdings
0.4%
Vaxcyte, Inc. (PCVX)
Wassil Jim — CHIEF OPERATING OFFICER
Shares
6
Price
$57.82
Total Value
$346.92
Shares Held After
156,760
% of Holdings
0.0%
Vaxcyte, Inc. (PCVX)
Wassil Jim — CHIEF OPERATING OFFICER
Shares
456
Price
$57.47
Total Value
$26.21K
Shares Held After
156,766
% of Holdings
0.3%
Vaxcyte, Inc. (PCVX)
Wassil Jim — CHIEF OPERATING OFFICER
Shares
1,788
Price
$56.03
Total Value
$100.18K
Shares Held After
157,222
% of Holdings
1.1%
Jazz Pharmaceuticals plc (JAZZ)
COZADD BRUCE C — Director
Shares
6,000
Price
$240.47
Total Value
$1.44M
Shares Held After
366,682
% of Holdings
1.6%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Liu Joy — EVP and Chief Legal Officer
Shares
828
Price
$502.71
Total Value
$416.24K
Shares Held After
19,131
% of Holdings
4.1%
Stoke Therapeutics, Inc. (STOK)
Ticho Barry — CHIEF MEDICAL OFFICER
Shares
500
Price
$33.27
Total Value
$16.63K
Shares Held After
27,598
% of Holdings
1.8%
Stoke Therapeutics, Inc. (STOK)
Ticho Barry — CHIEF MEDICAL OFFICER
Shares
6,728
Price
$32.62
Total Value
$219.43K
Shares Held After
28,098
% of Holdings
19.3%
Zai Lab Ltd (ZLAB)
GAYNOR RICHARD — Director
Shares
1,736
Price
$19.05
Total Value
$33.07K
Shares Held After
80,737
% of Holdings
2.2%
Liquidia Corp (LQDA)
Bloch Stephen M — Director
Shares
853
Price
$80.05
Total Value
$68.28K
Shares Held After
855,073
% of Holdings
0.1%
Liquidia Corp (LQDA)
Bloch Stephen M — Director
Shares
24,147
Price
$79.45
Total Value
$1.92M
Shares Held After
855,926
% of Holdings
2.7%
Boundless Bio, Inc. (BOLD)
ARCH Venture Fund IX, L.P. — 10% Owner
Shares
16,000
Price
$2.49
Total Value
$39.84K
Shares Held After
0
% of Holdings
100.0%
Boundless Bio, Inc. (BOLD)
CRANDELL KEITH — 10% Owner
Shares
16,000
Price
$2.49
Total Value
$39.84K
Shares Held After
0
% of Holdings
100.0%
Nuvalent, Inc. (NUVL)
Noci Darlene — Chief Development Officer
Shares
23,000
Price
$123.59
Total Value
$2.84M
Shares Held After
58,117
% of Holdings
28.4%
Intellia Therapeutics, Inc. (NTLA)
Dube Michael P — VP, Chief Accounting Officer
Shares
2,641
Price
$16.78
Total Value
$44.32K
Shares Held After
66,886
% of Holdings
3.8%
LIGAND PHARMACEUTICALS INC (LGND)
Reardon Andrew — CLO & Secretary
Shares
600
Price
$317.15
Total Value
$190.29K
Shares Held After
41,514
% of Holdings
1.4%
LIGAND PHARMACEUTICALS INC (LGND)
Reardon Andrew — CLO & Secretary
Shares
900
Price
$315.78
Total Value
$284.20K
Shares Held After
42,114
% of Holdings
2.1%
LIGAND PHARMACEUTICALS INC (LGND)
Reardon Andrew — CLO & Secretary
Shares
100
Price
$314.58
Total Value
$31.46K
Shares Held After
43,014
% of Holdings
0.2%
LIGAND PHARMACEUTICALS INC (LGND)
Reardon Andrew — CLO & Secretary
Shares
700
Price
$313.46
Total Value
$219.42K
Shares Held After
43,114
% of Holdings
1.6%
LIGAND PHARMACEUTICALS INC (LGND)
Reardon Andrew — CLO & Secretary
Shares
1,081
Price
$312.28
Total Value
$337.57K
Shares Held After
43,814
% of Holdings
2.4%
LIGAND PHARMACEUTICALS INC (LGND)
Reardon Andrew — CLO & Secretary
Shares
1,119
Price
$311.72
Total Value
$348.81K
Shares Held After
44,895
% of Holdings
2.4%
LIGAND PHARMACEUTICALS INC (LGND)
Reardon Andrew — CLO & Secretary
Shares
104
Price
$310.20
Total Value
$32.26K
Shares Held After
46,014
% of Holdings
0.2%
LIGAND PHARMACEUTICALS INC (LGND)
Reardon Andrew — CLO & Secretary
Shares
396
Price
$308.99
Total Value
$122.36K
Shares Held After
46,118
% of Holdings
0.9%
CORCEPT THERAPEUTICS INC (CORT)
Maduck Sean — President, Corcept Endocrinology
The power of attorney under which this form was signed is on file with the Commission.
Shares
11,175
Price
$89.31
Total Value
$998.03K
Shares Held After
9,755
% of Holdings
53.4%
CORCEPT THERAPEUTICS INC (CORT)
Maduck Sean — President, Corcept Endocrinology
The power of attorney under which this form was signed is on file with the Commission.
Shares
2,801
Price
$88.51
Total Value
$247.92K
Shares Held After
20,930
% of Holdings
11.8%
CORCEPT THERAPEUTICS INC (CORT)
Maduck Sean — President, Corcept Endocrinology
The power of attorney under which this form was signed is on file with the Commission.
Shares
11,024
Price
$87.33
Total Value
$962.78K
Shares Held After
23,731
% of Holdings
31.7%
Scholar Rock Holding Corp (SRRK)
Gilman Michael — Director
Shares
43
Price
$54.81
Total Value
$2.36K
Shares Held After
59,511
% of Holdings
0.1%
Showing 801–850 of 3396 transactions (page 17 of 68)